When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SYRS - Syros Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08 revenue of $78M beats by $73.16M
Syros Pharmaceuticals Inc.
Syros Pharmaceuticals press release (NASDAQ:SYRS): Q4 GAAP EPS of -$0.38 beats by $0.08. Revenue of $78M (+1268.4% Y/Y) beats by $73.16M. Cash, cash equivalents and marketable securities as of December 31, 2021 were $143.4M. The company believes that its existing cash, cash equivalents and marketable securities will be sufficient to fund its planned operating expenses and capital expenditure requirements into the first quarter of 2023.